). Antibodies against the following proteins had been used: pThr308Akt, Akt, pThr
). Antibodies against the following proteins have been utilized: pThr308Akt, Akt, pThr202/Tyr204ERKs, ERKs, pThr180/Tyr182p38, p38, PARP, pTyr705STAT3, STAT3, and PHLPP (Cell Signaling Technology, Danvers, MA); BRCA1 and p53 (Santa Cruz…